Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: Validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22)
Timothy P. Pearman*, Jennifer L. Beaumont, Diane Paul, Amy P. Abernethy, Paul B. Jacobsen, Karen L. Syrjala, Jamie Von Roenn, David Cella
Dive into the research topics of 'Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: Validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22)'. Together they form a unique fingerprint.